Back
Day Range
$15.90
$16.09
52-Week Range
$11.16
$17.54
Volume
100
50D / 200D Avg
$16.37
/
$14.41
Prev Close
$16.43
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 35.5 | 0.3 |
| P/B | 2.2 | 3.0 |
| ROE % | 7.4 | 3.7 |
| Net Margin % | 4.4 | 3.8 |
| Rev Growth 5Y % | 10.7 | 10.0 |
| D/E | 2.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.50
$0.48 – $0.53
|
1.17B | 1 |
| FY2026 |
$0.44
$0.42 – $0.46
|
1.14B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | N/A | $0.10 | — |
| 2025-08-12 | N/A | $0.04 | — |
| 2025-05-06 | N/A | $0.13 | — |
| 2025-02-18 | N/A | $0.07 | — |
| 2024-11-11 | N/A | $0.05 | — |
| 2024-08-08 | N/A | $0.06 | — |
| 2024-05-09 | N/A | $0.20 | — |
| 2024-02-20 | N/A | $0.00 | — |
Dividend History
Yield
0.04%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 15, 2026 | $0.06 | 4.26% |
| Feb 27, 2026 | Mar 13, 2026 | $0.06 | 3.90% |
| Jan 30, 2026 | Feb 13, 2026 | $0.06 | 4.29% |
| Dec 31, 2025 | Jan 15, 2026 | $0.06 | 4.48% |
| Nov 28, 2025 | Dec 15, 2025 | $0.06 | 4.49% |
| Oct 31, 2025 | Nov 14, 2025 | $0.06 | 5.00% |
| Sep 30, 2025 | Oct 15, 2025 | $0.06 | 4.95% |
| Aug 29, 2025 | Sep 15, 2025 | $0.06 | 5.19% |
| Jul 31, 2025 | Aug 15, 2025 | $0.06 | 5.18% |
| Jun 30, 2025 | Jul 15, 2025 | $0.06 | 4.95% |
| May 30, 2025 | Jun 13, 2025 | $0.06 | 5.12% |
| Apr 30, 2025 | May 15, 2025 | $0.06 | 5.54% |
| Mar 31, 2025 | Apr 15, 2025 | $0.05 | 5.83% |
| Feb 28, 2025 | Mar 14, 2025 | $0.05 | 5.89% |
| Jan 31, 2025 | Feb 14, 2025 | $0.05 | 6.19% |
| Dec 31, 2024 | Jan 15, 2025 | $0.05 | 6.27% |
| Nov 29, 2024 | Dec 13, 2024 | $0.06 | 5.70% |
| Oct 31, 2024 | Nov 15, 2024 | $0.06 | 5.50% |
| Sep 30, 2024 | Oct 15, 2024 | $0.06 | 5.55% |
| Aug 30, 2024 | Sep 13, 2024 | $0.06 | 6.10% |
Key Takeaways
Revenue grew 10.71% annually over 5 years — strong growth
Earnings grew 15.85% over the past year
Negative free cash flow of -42.83M
P/E of 35.52 — premium valuation
ROIC of 3.40% — low return on invested capital
Growth
Revenue Growth (5Y)
10.71%
Revenue (1Y)12.42%
Earnings (1Y)15.85%
FCF Growth (3Y)N/A
Quality
Return on Equity
7.42%
ROIC3.40%
Net Margin4.43%
Op. Margin9.68%
Safety
Debt / Equity
1.99
Current Ratio0.51
Interest Coverage2.15
Valuation
P/E Ratio
35.52
Forward P/EN/A
P/B Ratio2.20
EV/EBITDA29.71
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.42% | Revenue Growth (3Y) | 13.07% |
| Earnings Growth (1Y) | 15.85% | Earnings Growth (3Y) | 151.43% |
| Revenue Growth (5Y) | 10.71% | Earnings Growth (5Y) | 21.16% |
| Profitability | |||
| Revenue (TTM) | 1.00B | Net Income (TTM) | 44.49M |
| ROE | 7.42% | ROA | 1.76% |
| Gross Margin | 13.97% | Operating Margin | 9.68% |
| Net Margin | 4.43% | Free Cash Flow (TTM) | -42.83M |
| ROIC | 3.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.99 | Current Ratio | 0.51 |
| Interest Coverage | 2.15 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 35.52 | Forward P/E | N/A |
| P/B Ratio | 2.20 | P/S Ratio | 1.57 |
| PEG Ratio | -4.48 | Forward PEG | N/A |
| EV/EBITDA | 29.71 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -2.71% | ||
| Market Cap | 1.58B | Enterprise Value | 2.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.00B | 893.16M | 785.37M | 718.59M | 668.49M |
| Net Income | 44.49M | 38.40M | 7.04M | 10.67M | 20.65M |
| EPS (Diluted) | 0.48 | 0.53 | 0.10 | 0.15 | 0.31 |
| Gross Profit | 140.24M | 893.16M | 146.31M | 91.00M | 81.85M |
| Operating Income | 97.24M | 103.19M | 115.40M | 38.04M | 56.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.53B | 1.86B | 1.70B | 1.68B | 1.61B |
| Total Liabilities | 1.82B | 1.38B | 1.32B | 1.25B | 1.20B |
| Shareholders' Equity | 718.94M | 480.72M | 373.77M | 434.69M | 405.85M |
| Total Debt | 1.43B | 1.01B | 1.01B | 977.96M | 950.28M |
| Cash & Equivalents | 119.56M | 127.20M | 24.40M | 38.05M | 29.05M |
| Current Assets | 177.73M | 164.87M | 60.70M | 83.76M | 95.74M |
| Current Liabilities | 351.15M | 388.11M | 508.46M | 336.71M | 230.47M |